Neuro-Oncology Reviews

Volume 26 Number 6
31 March 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 6, 31 March

Brunasso L, Avallone C, Florena AM, Grasso G.
Infratentorial Relapsing Neuroglial Tumors in Adults: Management and Unsolved Issues-A Systematic Review.
Brain Sci. 2024 Mar 18;14(3):286. doi: 10.3390/brainsci14030286. PMID: 38539674. Review. ˍ

**Czarnywojtek A, Gut P, Dyrka K, Sowiński J, Sawicka-Gutaj N, Katulska K, Stajgis P, Wykrętowicz M, Moskal J, Kościński J, Pietrończyk K, Graczyk P, Krawczyński MR, Florek E, Szczepanek-Parulska E, Ruchała M, Ferlito A.
Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?
Endokrynol Pol. 2024 Mar 19. doi: 10.5603/ep.98240. PMID: 38646982. Case report; Review. ˍ

Mulhem A.
Primary glioblastoma multiform (GBM) of the optic nerve and chiasma: A case report and systematic review of the literature.
Clin Case Rep. 2024 Mar 20;12(3):e8636. doi: 10.1002/ccr3.8636. PMID: 38515994. Case report; Review. ˍ

Pöhlmann J, Weller M, Marcellusi A, Grabe-Heyne K, Krott-Coi L, Rabar S, Pollock RF.
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.
Front Oncol. 2024 Mar 20;14:1368606. doi: 10.3389/fonc.2024.1368606. PMID: 38571509. Review. ˍ

*Sun B, Sun Y, Wang Z, Zhao C, Yang L.
Prevalence and risk factors of early postoperative seizures in patients with glioma: a systematic review and meta-analysis.
Front Neurol. 2024 Mar 20;15:1356715. doi: 10.3389/fneur.2024.1356715. PMID: 38572493. Review; Meta-analysis. ˍ

Aghajani M, Jalilzadeh N, Aghebati-Maleki A, Yari A, Tabnak P, Mardi A, Saeedi H, Aghebati-Maleki L, Baradaran B.
Current approaches in glioblastoma multiforme immunotherapy.
Clin Transl Oncol. 2024 Mar 21. doi: 10.1007/s12094-024-03395-7. PMID: 38512448. Review˰ ˍ

Salvato I, Marchini A.
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives.
Cancers (Basel). 2024 Mar 25;16(7):1276. doi: 10.3390/cancers16071276. PMID: 38610954. Review. ˍ

Begley SL, McBriar JD, Pelcher I, Schulder M.
Intraoperative MRI: A Review of Applications Across Neurosurgical Specialties.
Neurosurgery. 2024 Mar 26. doi: 10.1227/neu.0000000000002933. PMID: 38530004. Review˰ ˍ

Ohnishi T.
Current Status and Future Perspective in Glioma Invasion Research.
Brain Sci. 2024 Mar 26;14(4):309. doi: 10.3390/brainsci14040309. PMID: 38671961. Editorial. ˍ

*Watanabe S, Nonaka T, Maeda M, Yamada M, Sugii N, Hashimoto K, Takano S, Koyanagi T, Arakawa Y, Ishikawa E.
Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints.
Ther Innov Regul Sci. 2024 Mar 26. doi: 10.1007/s43441-024-00644-3. PMID: 38530629. Review; Meta-analysis. ˍ

Fernandez-Gil BI, Larion M.
Editorial: CNS tumor metabolism: targets, markers, and challenges.
Front Cell Neurosci. 2024 Mar 27;18:1401687. doi: 10.3389/fncel.2024.1401687. PMID: 38601024. Editorial. ˍ

Nabavizadeh A, Galldiks N, Veronesi M, Lohmann P, McConathy JE, Johnson DR, Aboian MS, Barajas RF Jr, Ivanidze J.
Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group.
AJNR Am J Neuroradiol. 2024 Mar 28. doi: 10.3174/ajnr.A8243. PMID: 38548306. Editorial˰ ˍ

Schirrmacher V, Van Gool S, Stuecker W.
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution.
Biomedicines. 2024 Mar 28;12(4):754. doi: 10.3390/biomedicines12040754. PMID: 38672110. Review. ˍ

Valerius AR, Webb LM, Sener U.
Novel Clinical Trials and Approaches in the Management of Glioblastoma.
Curr Oncol Rep. 2024 Mar 28. doi: 10.1007/s11912-024-01519-4. PMID: 38546941. Review˰ ˍ

*Khalighi S, Reddy K, Midya A, Pandav KB, Madabhushi A, Abedalthagafi M.
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment.
NPJ Precis Oncol. 2024 Mar 29;8(1):80. doi: 10.1038/s41698-024-00575-0. PMID: 38553633. Review. ˍ

Menegaz de Almeida A, Viana P, Marinheiro G, Hoffmann Relvas J, Lopes L, Lima Guilherme G, Zanette Giusti JA, Oliveira P, Azevedo Silva Kaiser Cabral MA, Carvalho Santos R, Medani K.
Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: A Systematic Review and Updated Meta-Analysis.
Neurosurgery. 2024 Mar 29. doi: 10.1227/neu.0000000000002929. PMID: 38551382. Review; Meta-Analysis˰ ˍ

Virtuoso A, D'Amico G, Scalia F, De Luca C, Papa M, Maugeri G, D'Agata V, Caruso Bavisotto C, D'Amico AG.
The Interplay between Glioblastoma Cells and Tumor Microenvironment: New Perspectives for Early Diagnosis and Targeted Cancer Therapy.
Brain Sci. 2024 Mar 29;14(4):331. doi: 10.3390/brainsci14040331. PMID: 38671983. Review. ˍ

Katole VR, Kaple M.
Unraveling the Landscape of Pediatric Glioblastoma Biomarkers: A Comprehensive Review of Enhancing Diagnostics and Therapeutic Insights.
Cureus. 2024 Mar 30;16(3):e57272. doi: 10.7759/cureus.57272. PMID: 38686271. Review. ˍ

Liu Y, Tang Q, Tao Q, Dong H, Shi Z, Zhou L.
Low-frequency magnetic field therapy for glioblastoma: Current advances, mechanisms, challenges and future perspectives.
J Adv Res. 2024 Mar 31:S2090-1232(24)00125-5. doi: 10.1016/j.jare.2024.03.024. PMID: 38565404. Review. ˍ